Boston Scientific (BSX) Inventory (2009 - 2026)

Boston Scientific (BSX) has 18 years of Inventory data on file, last reported at $3.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 8.72% year-over-year to $3.1 billion; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (up 8.72% YoY), and the FY2025 full-year result was $2.9 billion, up 4.73% from the prior year.
• Inventory climbed to $3.1 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $3.1 billion in Q1 2026 to a low of $1.7 billion in Q1 2022.
• A 5-year average of $2.5 billion and a median of $2.6 billion in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 34.45% in 2023 and rose 4.73% in 2025, its largest moves.
• Tracing BSX's Inventory over 5 years: stood at $1.9 billion in 2022, then jumped by 33.05% to $2.5 billion in 2023, then gained by 13.12% to $2.8 billion in 2024, then advanced by 4.73% to $2.9 billion in 2025, then gained by 5.91% to $3.1 billion in 2026.
• Business Quant data shows BSX's Inventory at $3.1 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.